This is a Validated Antibody Database (VAD) review about human CD30, based on 32 published articles (read how Labome selects the articles), using CD30 antibody in all methods. It is aimed to help Labome visitors find the most suited CD30 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD30 synonym: CD30; D1S166E; Ki-1

BioLegend
mouse monoclonal (BY88)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD30 antibody (Biolegend, 333918) was used in flow cytometry on human samples (fig 2c). Nat Commun (2020) ncbi
Santa Cruz Biotechnology
mouse monoclonal (C-3)
  • immunohistochemistry - paraffin section; human; 1:200
Santa Cruz Biotechnology CD30 antibody (Santa Cruz, sc-46683) was used in immunohistochemistry - paraffin section on human samples at 1:200. Oncol Lett (2016) ncbi
mouse monoclonal (Ber-H2)
  • western blot; human
Santa Cruz Biotechnology CD30 antibody (Santa Cruz Biotechnology, sc-19658) was used in western blot on human samples . Mol Cancer Ther (2014) ncbi
Invitrogen
mouse monoclonal (MEM-268)
  • immunohistochemistry - paraffin section; human; 1:50
Invitrogen CD30 antibody (Life Technologies, MEM-268) was used in immunohistochemistry - paraffin section on human samples at 1:50. Pathol Res Pract (2014) ncbi
Dako
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1b
Dako CD30 antibody (Dako, Ber-H2) was used in immunohistochemistry - paraffin section on human samples (fig s1b). Int J Mol Sci (2022) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; 1:10; loading ...; tbl 2
Dako CD30 antibody (Dako, M075101) was used in immunohistochemistry - paraffin section on human samples at 1:10 (tbl 2). Am J Surg Pathol (2017) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
In order to characterize three immunocompetent patients with primary cardiac diffuse large B-cell lymphoma, Dako CD30 antibody (Dako, Ber-H2) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Ann Diagn Pathol (2016) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 3
In order to characterize cases of recurrent panniculitis in children with lipoatrophy, Dako CD30 antibody (DAKO, Ber-H2) was used in immunohistochemistry - paraffin section on human samples (tbl 3). J Eur Acad Dermatol Venereol (2017) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; 1:1200; loading ...
Dako CD30 antibody (Dako, M07G1) was used in immunohistochemistry - paraffin section on human samples at 1:1200. Oncol Lett (2016) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
Dako CD30 antibody (DAKO, Ber-H2) was used in immunohistochemistry - paraffin section on human samples (fig 2). Int J STD AIDS (2017) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; 1:10; loading ...
In order to characterize and present the first case of fibroblastic reticular cell tumor of the breast, Dako CD30 antibody (Dako, Ber.H2) was used in immunohistochemistry - paraffin section on human samples at 1:10. Exp Ther Med (2016) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
Dako CD30 antibody (Dako, Ber-H2) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Stem Cells Int (2016) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; 1:40; fig 1
In order to determine the activation of PRC2, H3K27me3, and BMI1 in T and natural killer cell lymphomas, Dako CD30 antibody (DAKO, Ber-H2) was used in immunohistochemistry - paraffin section on human samples at 1:40 (fig 1). Tumour Biol (2016) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathological features of 15 patients with Epstein-Barr virus-positive nodal T/NK-cell lymphoma, Dako CD30 antibody (Dako, Ber-H2) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry; human; 1:20
In order to describe a new method for immunohistochemistry optimization, Dako CD30 antibody (DakoCytomation, M0751) was used in immunohistochemistry on human samples at 1:20. Histopathology (2015) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry; human; tbl 3
In order to compare the clinicopathologic profiles of patients with nodal Epstein-Barr virus cytotoxic T-cell lymphoma with those with extranasal NK/T-cell lymphoma, Dako CD30 antibody (Dako, BerH2) was used in immunohistochemistry on human samples (tbl 3). Am J Surg Pathol (2015) ncbi
mouse monoclonal (Ber-H2)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, Dako CD30 antibody (Dako, BER-H2) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human
Dako CD30 antibody (Dako, Ber-H2) was used in immunohistochemistry - paraffin section on human samples . J Cutan Pathol (2015) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human; ready-to-use
In order to determine if the presence of the DUSP22-IRF4 translocation is a distinctive histological features in patients with cutaneous anaplastic large cell lymphoma, Dako CD30 antibody (Dako, Ber-H2) was used in immunohistochemistry - paraffin section on human samples at ready-to-use. Histopathology (2015) ncbi
mouse monoclonal (Ber-H2)
  • blocking or activating experiments; human
Dako CD30 antibody (Dako, M0751) was used in blocking or activating experiments on human samples . Int J Oncol (2014) ncbi
mouse monoclonal (Ber-H2)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, Dako CD30 antibody (Dako, clone BER-H2) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (Ber-H2)
  • immunohistochemistry - paraffin section; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Dako CD30 antibody (Dako, BerH2) was used in immunohistochemistry - paraffin section on human samples . Int J Surg Pathol (2014) ncbi
Beckman Coulter
mouse monoclonal (HRS4)
  • flow cytometry; human; fig 3
In order to characterize two cases of anaplastic large cell lymphoma using flow cytometry, Beckman Coulter CD30 antibody (Beckman Coulter, HRS4) was used in flow cytometry on human samples (fig 3). Cytometry B Clin Cytom (2015) ncbi
BD Biosciences
mouse monoclonal (BerH8)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD30 antibody (BD Biosciences, Ber-H8) was used in flow cytometry on human samples (fig 1a). Int J Mol Sci (2022) ncbi
mouse monoclonal (BerH8)
  • western blot; human; 1:100; loading ...; fig 2b
BD Biosciences CD30 antibody (BD Biosciences, clone BerH8;555827) was used in western blot on human samples at 1:100 (fig 2b). Nat Commun (2020) ncbi
mouse monoclonal (BerH8)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD30 antibody (Miltenyi Biotec Inc, 550041) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (Ber-H83)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD30 antibody (BD Biosciences, Ber-H83) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (BerH8)
  • flow cytometry; human; loading ...; fig 6a
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, BD Biosciences CD30 antibody (BD Biosciences, 550041) was used in flow cytometry on human samples (fig 6a). Oncotarget (2016) ncbi
mouse monoclonal (BerH8)
  • flow cytometry; human; fig s4
In order to assess the effects of lenalidomide on normal human plasma cell generation, BD Biosciences CD30 antibody (BD Biosciences, BerH8) was used in flow cytometry on human samples (fig s4). Oncotarget (2016) ncbi
mouse monoclonal (BerH8)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD30 antibody (BD, 550041) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (BerH8)
  • flow cytometry; human; fig 1f
In order to measure the expression of antigens on malignant human plasma cells that have exhibited promise in targeted cancer therapy, BD Biosciences CD30 antibody (BD, BerH8) was used in flow cytometry on human samples (fig 1f). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (BerH8)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, BD Biosciences CD30 antibody (BD Bioscience, Ber-H83) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (Ber-H83)
  • flow cytometry; human; fig 1
In order to identify alterations in genes involved in antigen presentation, chromosome integrity, transcriptional regulation, and ubiquitination in Hodgkin and Reed-Sternberg cells, BD Biosciences CD30 antibody (Beckton-Dickinson, BerH83) was used in flow cytometry on human samples (fig 1). Blood (2015) ncbi
mouse monoclonal (Ber-H83)
  • flow cytometry; human; fig 3
In order to characterize two cases of anaplastic large cell lymphoma using flow cytometry, BD Biosciences CD30 antibody (Becton Dickinson, Ber-H83) was used in flow cytometry on human samples (fig 3). Cytometry B Clin Cytom (2015) ncbi
Leica Biosystems
monoclonal (JCM182)
  • immunohistochemistry; human; loading ...; fig 2e
Leica Biosystems CD30 antibody (Leica Biosystems, PA0799) was used in immunohistochemistry on human samples (fig 2e). Sci Rep (2016) ncbi
Articles Reviewed
  1. Pellegrini S, Zamarian V, Landi E, Cospito A, Lombardo M, Manenti F, et al. Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation. Int J Mol Sci. 2022;23: pubmed publisher
  2. Olafsdottir T, Theodors F, Bjarnadóttir K, Bjornsdottir U, Agustsdottir A, Stefansson O, et al. Eighty-eight variants highlight the role of T cell regulation and airway remodeling in asthma pathogenesis. Nat Commun. 2020;11:393 pubmed publisher
  3. Weniger M, Tiacci E, Schneider S, Arnolds J, Rüschenbaum S, Duppach J, et al. Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells. J Clin Invest. 2018;128:2996-3007 pubmed publisher
  4. Ohtsuka T, Sakaguchi M, Yamamoto H, Tomida S, Takata K, Shien K, et al. Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway. Sci Rep. 2016;6:39557 pubmed publisher
  5. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  6. Gentry M, Bodo J, Durkin L, Hsi E. Performance of a Commercially Available MAL Antibody in the Diagnosis of Primary Mediastinal Large B-Cell Lymphoma. Am J Surg Pathol. 2017;41:189-194 pubmed publisher
  7. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  8. Soon G, Ow G, Chan H, Ng S, Wang S. Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases. Ann Diagn Pathol. 2016;24:40-6 pubmed publisher
  9. Wang L, Xu D, Qiao Z, Shen L, Dai H, Ji Y. Follicular dendritic cell sarcoma of the spleen: A case report and review of the literature. Oncol Lett. 2016;12:2062-2064 pubmed
  10. Torrelo A, Noguera Morel L, Hernandez Martin A, Clemente D, Barja J, Buzon L, et al. Recurrent lipoatrophic panniculitis of children. J Eur Acad Dermatol Venereol. 2017;31:536-543 pubmed publisher
  11. Fu T, Yang W, Zhang X, Xu X. Peripheral T-cell lymphoma unspecified type presenting with a pneumothorax as the initial manifestation: A case report and literature review. Oncol Lett. 2016;11:4069-4076 pubmed
  12. Wang D, Zheng Y, Zeng D, Yang Y, Zhang X, Feng Y, et al. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma. Int J STD AIDS. 2017;28:380-388 pubmed publisher
  13. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed publisher
  14. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  15. Li H, Shen P, Liang Y, Zhang F. Fibroblastic reticular cell tumor of the breast: A case report and review of the literature. Exp Ther Med. 2016;11:561-564 pubmed
  16. Unzu C, Friedli M, Bosman A, Jaconi M, Wildhaber B, Rougemont A. Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues. Stem Cells Int. 2016;2016:4370142 pubmed publisher
  17. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed publisher
  18. Kim S, Yang W, Min Y, Ko Y, Yoon S. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications. Tumour Biol. 2016;37:2037-47 pubmed publisher
  19. Jeon Y, Kim J, Sung J, Han J, Ko Y. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015;46:981-90 pubmed publisher
  20. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  21. Kap M, Lam K, Ewing Graham P, Riegman P. A reference image-based method for optimization of clinical immunohistochemistry. Histopathology. 2015;67:193-205 pubmed publisher
  22. Kato S, Asano N, Miyata Takata T, Takata K, Elsayed A, Satou A, et al. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases. Am J Surg Pathol. 2015;39:462-71 pubmed publisher
  23. Reichel J, Chadburn A, Rubinstein P, Giulino Roth L, Tam W, Liu Y, et al. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2015;125:1061-72 pubmed publisher
  24. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  25. Wang L, Wang G, Gao T. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis. J Cutan Pathol. 2015;42:265-70 pubmed publisher
  26. Hasanali Z, Epner E, Feith D, Loughran T, Sample C. Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytes. Mol Cancer Ther. 2014;13:2784-92 pubmed publisher
  27. Onaindia A, Montes Moreno S, Rodriguez Pinilla S, Batlle A, Gonzalez de Villambrosia S, Rodriguez A, et al. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features. Histopathology. 2015;66:846-55 pubmed publisher
  28. Wu D, Allen C, Fromm J. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue. Cytometry B Clin Cytom. 2015;88:58-63 pubmed publisher
  29. Changchien Y, Bocskai P, Kovacs I, Hargitai Z, Kollár S, Torok M. Pleomorphic hyalinizing angiectatic tumor of soft parts: case report with unusual ganglion-like cells and review of the literature. Pathol Res Pract. 2014;210:1146-51 pubmed publisher
  30. Suzuki O, Abe M. Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: regulatory roles of cell surface glycans. Int J Oncol. 2014;44:1433-42 pubmed publisher
  31. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  32. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher